Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Javier Cortès"'
Autor:
Isabella Sala, Eleonora Pagan, Laura Pala, Chiara Oriecuia, Marco Musca, Claudia Specchia, Tommaso De Pas, Javier Cortes, Giuseppe Giaccone, Michael Postow, Richard D. Gelber, Vincenzo Bagnardi, Fabio Conforti
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThere is debate on which are the best surrogate endpoint and metric to capture treatment effect on overall survival (OS) in RCTs testing immune-checkpoint inhibitors (ICIs).MethodsWe systematically searched for RCTs testing ICIs in patien
Externí odkaz:
https://doaj.org/article/41a1befd79f048e8a9b532a6878b8f02
Autor:
Andrea Aran, Gonzalo Lázaro, Vicente Marco, Elisa Molina, Ferran Abancó, Vicente Peg, María Gión, Laia Garrigós, José Pérez-García, Javier Cortés, Mercè Martí
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTumor-infiltrating lymphocytes (TILs) have predictive and prognostic value in breast cancer (BC) and exert a protective function against tumor growth, indicating that it is susceptible to treatment using adoptive cell transfer of TILs or
Externí odkaz:
https://doaj.org/article/51d7b57a14774f8d885aa0d82175ee93
Autor:
Miguel Sampayo-Cordero, Bernat Miguel-Huguet, Andrea Malfettone, Elena López-Miranda, María Gion, Elena Abad, Daniel Alcalá-López, Jhudit Pérez-Escuredo, José Manuel Pérez-García, Antonio Llombart-Cussac, Javier Cortés
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
De-escalation trials in oncology evaluate therapies that aim to improve the quality of life of patients with low-risk cancer by avoiding overtreatment. Non-inferiority randomized trials are commonly used to investigate de-intensified regimens with si
Externí odkaz:
https://doaj.org/article/4129d5abe3b54a4aa1163a0967a18f28
Autor:
Ángela Quintana, Enrique Javier Arenas, Cristina Bernadó, José Fernández Navarro, Jonatan González, Anna Esteve-Codina, Teresa Moliné, Merce Marti, Giuseppe Curigliano, Peter Schmid, Vicente Peg, Joaquín Arribas, Javier Cortés
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTumor infiltrating lymphocytes (TILs) are known to be a prognostic and predictive biomarker in breast cancer, particularly in triple negative breast cancer (TNBC) patients. International guidelines have been proposed to evaluate them in t
Externí odkaz:
https://doaj.org/article/b12b9107a3c848078a4ede6efaf4d2df
Autor:
Manuela Monti, Tom Degenhardt, Etienne Brain, Rachel Wuerstlein, Alessandra Argusti, Matteo Puntoni, Gian Andrea Rollandi, Davide Corradengo, Luca Boni, Harun Ilhan, Oriana Nanni, Javier Cortes, Alejandro Piris-Gimenez, Arnoldo Piccardo, Massimiliano Iacozzi, Federica Matteucci, Valentina Di Iorio, Jean Louis Alberini, Carolien Schröder, Nadia Harbeck, Alessandra Gennari
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Background: Academic research is important to face unmet medical needs. The Oncological community encounters many hurdles in setting up multicenter investigator-driven trials mainly due to administrative complexity. The purpose of a network organizat
Externí odkaz:
https://doaj.org/article/a08e1d94b5794d59b8d70e7dab7c78f2
Autor:
Andrea Aran, Vicente Peg, Rosa Maria Rabanal, Cristina Bernadó, Esther Zamora, Elisa Molina, Yago A. Arribas, Joaquín Arribas, José Pérez, Carme Roura-Mir, Montserrat Carrascal, Javier Cortés, Mercè Martí
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
EBV-specific T cells have been recently described to be involved in fatal encephalitis and myocarditis in cancer patients after immune checkpoint therapies. Here, we report the study of a human triple-negative breast cancer tumor (TNBC) and EBV-trans
Externí odkaz:
https://doaj.org/article/d7e27f34772049269cfa3d1b3c5e3466
Autor:
Miguel Sampayo-Cordero, Bernat Miguel-Huguet, Andrea Malfettone, José Manuel Pérez-García, Antonio Llombart-Cussac, Javier Cortés, Almudena Pardo, Jordi Pérez-López
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Nonrandomized studies are usually excluded from systematic reviews. This could lead to loss of a considerable amount of information on rare diseases. In this article, we explore the impact of excluding nonrandomized studies on the generalizability of
Externí odkaz:
https://doaj.org/article/9f4d7fc64b8344aa8a9954194506836c
Autor:
Diogo Alpuim Costa, José Guilherme Nobre, Marta Vaz Batista, Catarina Ribeiro, Catarina Calle, Alfonso Cortes, Maximilian Marhold, Ida Negreiros, Paula Borralho, Miguel Brito, Javier Cortes, Sofia Azambuja Braga, Luís Costa
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Breast cancer (BC) is the most common malignancy and the second cause of cancer-specific death in women from high-income countries. Recently, gut microbiota dysbiosis emerged as a key player that may directly and/or indirectly influence development,
Externí odkaz:
https://doaj.org/article/c90f8d4747f64cee96c426ad8df941d5
Autor:
Andrea Feliciano, Lucila González, Yoelsis Garcia-Mayea, Cristina Mir, Mireia Artola, Nieves Barragán, Remedios Martín, Anna Altés, Josep Castellvi, Sergi Benavente, Santiago Ramón y Cajal, Martín Espinosa-Bravo, Javier Cortés, Isabel T. Rubio, Matilde E. LLeonart
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Breast cancer is the cancer with the most incidence and mortality in women. microRNAs are emerging as novel prognosis/diagnostic tools. Our aim was to identify a serum microRNA signature useful to predict cancer development. We focused on studying th
Externí odkaz:
https://doaj.org/article/2323d22a0b5345ba9b9922f9ab5bb7a7
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Externí odkaz:
https://doaj.org/article/a5dc75b2f1c34561962491e66e580be9